|
Report No. : |
317916 |
|
Report Date : |
23.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
PHARMASCIENCE INC. |
|
|
|
|
Registered Office : |
6111 Avenue Royalmount, Ste 100, Montreal, Quebec H4P 2T4 |
|
|
|
|
Country : |
Canada |
|
|
|
|
Year of Establishment : |
1983 |
|
|
|
|
Legal Form : |
Federal Corporation – Profit |
|
|
|
|
Line of Business : |
Subject is engaged in develops and manufacturing and Selling generic
pharmaceutical products |
|
|
|
|
No. of Employee : |
2,000 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Canada |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CANADA - ECONOMIC OVERVIEW
As a high-tech industrial society in the trillion-dollar class, Canada resembles the US in its market-oriented economic system, pattern of production, and high living standards. Since World War II, the impressive growth of the manufacturing, mining, and service sectors has transformed the nation from a largely rural economy into one primarily industrial and urban. The 1989 US-Canada Free Trade Agreement (FTA) and the 1994 North American Free Trade Agreement (NAFTA) (which includes Mexico) touched off a dramatic increase in trade and economic integration with the US, its principal trading partner. Canada enjoys a substantial trade surplus with the US, which absorbs about three-fourths of Canadian merchandise exports each year. Canada is the US's largest foreign supplier of energy, including oil, gas, uranium, and electric power. Given its abundant natural resources, highly skilled labor force, and modern capital plant, Canada enjoyed solid economic growth from 1993 through 2007. Buffeted by the global economic crisis, the economy dropped into a sharp recession in the final months of 2008, and Ottawa posted its first fiscal deficit in 2009 after 12 years of surplus. Canada's major banks, however, emerged from the financial crisis of 2008-09 among the strongest in the world, owing to the early intervention by the Bank of Canada and the financial sector's tradition of conservative lending practices and strong capitalization. Canada achieved marginal growth in 2010-14 and plans to balance the budget by 2015. In addition, the country's petroleum sector is rapidly expanding, because Alberta's oil sands significantly boosted Canada's proven oil reserves. Canada now ranks third in the world in proved oil reserves behind Saudi Arabia and Venezuela.
|
Source
: CIA |
PHARMASCIENCE INC.
6111 Avenue Royalmount, Ste 100, Montreal, Quebec H4P 2T4
Canada
Telephone: +1 514-340-9800
Fax: +1 514-342-7764
Website: www.pharmascience.com
Corporate ID#: 4305817
State: Federal
Judicial form: Federal Corporation – Profit
A Federal Corporation is allowed to do
business in all the
Country.
Date incorporated: 05-31-2005
Date founded: 1983
Stock: -
Value: -
David W. GOODMAN
History:
Business issued from the
merger of:
- PHARMASCIENCE INC.
- PENDOPHARM INC.
Business:
Pharmascience, Inc. operates as a generic pharmaceutical company in Canada.
It develops and manufactures generic pharmaceutical products, including
analgesic, antianginal, anti-infective, calcium/vitamins, cardiovascular,
central nervous system, cholesterol reduction agents, dermatology, diabetes,
endocrine therapy, GI therapy, ophthalmic, psychotherapeutics, and respiratory
drug therapies; prescription medicines and consumer products (OTC/BTC) in
various therapeutic categories, such as pain management, gastro-intestinal
disorders, nasal hygiene, and oral re-hydration; and a range of dosage forms,
including liquids, tablets, capsules, suppositories, powders, ophthalmics,
sterile products for inhalation, gels, injectables, ointments, creams, nasal
solutions, and suspensions.
The company also sells pharmaceutical products to hospitals and
institutions in Canada; and supplies diagnostics and medical devices.
It provides healthcare products and related services to healthcare
professionals and patients around the world.
The company was founded in 1983 and is based in Montréal, Canada.
Pharmascience, Inc. operates as a subsidiary of Joddes Limited.
The Company is
using several names including:
|
AEGERA THERAPEUTIQUES |
|
AMD RITMED |
|
LABORATOIRES ADAMS |
|
LABORATOIRES LEE ADAMS |
|
PENDOPHARM, A DIVISION OF PHARMASCIENCE INC. |
|
PENDOPHARM, UNE DIVISION DE PHARMASCIENCE INC. |
|
PHARMACAL DOMINION |
|
PHARMACEUTIQUE ROYALMOUNT |
|
PHARMACEUTIQUES RIVEX |
|
RITMED |
|
RIVEX, UNE DIVISION DE PHARMASCIENCE |
|
ROYALMOUNT PHARMACEUTICALS |
Staff: 2,000+
Operations & branches:
At the headquarters, we
find the corporate office.
The Company maintains
factories located:
5950, Côte-de-Liesse,
Mont-Royal, Quebec, H4T 1E2, Canada.
8580 De L'Esplanade
Montreal, Quebec, H2P 2S2, Canada.
6625 Abrams
Saint-Laurent, Quebec, H4S 1V9, Canada.
JODDES LIMITE
6111 Avenue Royalmount, Ste 100, Montreal, Quebec H4P 2T4
David GOODMAN is Vice President and CEO.
Mr. Goodman served as an Executive Vice President of International Operations
at Pharmascience Inc.
He holds a Bachelor's Degree in Commerce from McGill University, and his
Ph.D. in Pharmacology from the University of Virginia
Morris GOODMAN is the Chairman and President
Mr. Morris Goodman co-founded Pharmascience Inc., in 1983 and serves as
its Chairman of the Board.
Mr. Goodman graduated from the Faculty of Pharmacy at the University of
Montreal in 1953 at the age of twenty-one, the youngest graduate of that
faculty at the time, and obtained the University of Montreal’s Prize for
Success.
Laurence MACGIRR serves as Chief Operations Officer of Pharmascience
Inc.
Mr. Macgirr has a dynamic, personable leadership style. He is
responsible for the strategic oversight of Pharmascience, inspiring out of the
box thinking throughout Pharmascience Inc. During his 17 years at Ciba Vision
Corp., he served as Vice President Sales-North American Lens Business and
served as its General Manager-Canada.
Throughout his career, he has been a keen advocate of fostering strong
relationships, connecting with clients and business partners alike, generating
profound insights that benefit their business in unexpected ways.
He also participated in executive-focused programs at Harvard and
Cornell.
He holds a Bachelor degree in Business Administration form York
University.
As far as we know, they are involved in several corporations including:
JODDES LIMITE
6111 Avenue Royalmount, Ste 100, Montreal, Quebec H4P 2T4
PCRI INC.
6111 Avenue Royalmount, Ste 100, Montreal, Quebec H4P 2T4
In Canada, privately held
corporations are not required to publish any financials.
On a direct call, a
financial assistant controlled the present report but deferred any financials.
We sent a fax but no answer
received.
However, sales estimate for
year 2014 is in the range of CAD 750,000,000=
The business is said to be
profitable.
Banks: Banque de Montreal
Banque
Nationale du Canada
Legal filings & complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts summary: Several